UNITED STATES – Dec 13 – LIV Process Founder & CEO Michael McIntyre has been selected as an international speaker at the 5th Infection Prevention & Control International Conference, taking place December 14–15, 2025, in Riyadh, Kingdom of Saudi Arabia.

The conference is recognized as one of the region’s leading platforms dedicated to advancing infection prevention, improving patient safety, and strengthening global health security. This year’s event is closely aligned with Saudi Arabia’s Vision 2030 Health Sector Transformation, which emphasizes innovation, system modernization, and improved care standards across the Kingdom.

McIntyre will present LIV Process’ breakthrough microbial visualization technology the first and only solution that illuminates dangerous pathogens such as Clostridioides difficile (C. diff) on surfaces, allowing hospitals to verify cleaning effectiveness in real time and reduce infection risk.

“The LIV Process solution evolved from one simple question: How can you solve a problem that you cannot see?” said Michael McIntyre, Founder & CEO. “It’s an honor to join global leaders in Riyadh who share a commitment to stronger infection-prevention practices. Microbial visualization represents a new chapter in environmental hygiene and an opportunity to support safer care environments and better patient outcomes worldwide.”

LIV Process’ mission, “Save Lives Now,” reflects its purpose-driven focus on equipping frontline healthcare workers with tools to detect contamination that would otherwise remain invisible. By enabling real-time visualization of microbial hotspots, LIV Process helps hospitals and care facilities strengthen infection control programs and enhance patient safety.

The two-day congress features keynote lectures, panel discussions, case studies, and workshops exploring evidence-based IPC strategies and solutions designed to reduce healthcare-associated infections across clinical and public health settings.

LIV Process continues to expand its footprint through new partnerships and research collaborations with leading U.S. health systems, as well as growing international interest in its microbial visualization platform.